Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
|
|
ACELRX PHARMACEUTICALS INC (ACRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/16/2013 |
8-K
| Appointed a new director|
Docs:
|
"AcelRx Pharmaceuticals Adds New Board Member REDWOOD CITY, Calif., December 11, 2013 - AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard F. Afable, M.D., president and CEO of Covenant Health Network, was appointed to the company's board of directors. Guy Nohra, co-founder and managing director of venture capital firm Alta Partners, resigned from the board as of December 10, 2013. “As CEO of an integrated healthcare delivery network that includes seven hospitals, Dr. Afable is at the forefront of changing how healthcare is delivered in the US. We are delighted that Rick is going to be able to bring those insights to AcelRx,” ..." |
|
|
|